Who We Are
TURKEY’S NEW GENERATION BIOTECHNOLOGY BASE
Biotechnology centre Stembio was established in 2020 in TÜBİTAK MARTEK R&D and Innovation zone in order to bring new health technologies developed at cellular and molecular level in the world to Turkey and to support the production of new knowledge in this field.
Providing services in the fields of stem cell and tissue technologies, Stembio is the first and only hybrid cell and tissue centre in Turkey.
Featured
- Audit and Quality
- High med-tech
- Extensive supply chain
- 36+ approved products
mision
We strive to maximise our services within the framework of scientific and ethical values and to create sustainable and reliable processes by applying advanced technology standards.
Vision
We want to pioneer the future of medicine in Turkey as a new generation biotechnology company that brings the health technologies developed at the cellular and molecular level in the world to our country.
Health, Safety and Environment Policy
Stembio, which continues its activities within the framework of basic principles that protect the environment, respect nature and do not harm the ecosystem, has adopted effective environmental management practices and a policy of continuous improvement of environmental performance criteria by prioritising human and environmental health.
OUR UNITS
Production Unit
The production unit, which operates in cGMP B and A class sterile areas located in cGMP B and C class laboratories, has the ability to process both cell and tissue products within the same time frame. This feature is available in very few centres in the world.
Quality Control Unit
This unit has the infrastructure and equipment to perform sterility, toxicity, pyrogenicity, genetic analyses, tumourigenicity analyses, flow-cytometry analyses, cellular analyses and environmental quality control procedures. All necessary quality controls of all raw cells and tissues, consumables and all cell and tissue products coming to the Centre are carried out in this unit. The unit is able to keep under control 24/7 that the Centre meets cGMP environmental standards.
Cryopreservation Unit
In our cryopreservation unit, which has the capacity to bank 20,000 cellular products, 10,000 cord blood and 10,000 tissue products with our existing infrastructure in GMP-controlled areas, there are liquid nitrogen tanks, -86°C deep freezers, stepwise freezing devices where cells and tissues can be frozen without losing their vitality.
Product Acceptance Unit
It is the unit where all raw cell and tissue materials and consumables coming to the centre are taken to the quarantine areas, sampled and accepted to the centre after the necessary controls are carried out.
